2011
DOI: 10.1007/s10529-011-0578-8
|View full text |Cite
|
Sign up to set email alerts
|

Highly enantioselective bioreduction of N-methyl-3-oxo-3-(thiophen-2-yl) propanamide for the production of (S)-duloxetine

Abstract: Whole cells of Rhodotorula glutinis reduced N-methyl-3-oxo-3-(thiophen-2-yl) propanamide at 30 g/l to (S)-N-methyl-3-hydroxy-3-(2-thienyl) propionamide, an intermediate in the production of (S)-duloxetine, a blockbuster antidepressant drug, in 48 h. The reaction had excellent enantioselectivity (single enantiomer, [99.5% enantiomeric excess [ee]) with a[95% conversion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 15 publications
0
9
0
Order By: Relevance
“…8). The reaction afforded much higher substrate tolerance than previously reported bioreduction of duloxetine precursors [16,21,37,38]. For the same substrate, previous study used high concentration of whole cells of R. glutinis (42 g CDW/l), which yielded compromised stereoselectivity when substrate concentration exceeded 30 g/l [16].…”
Section: Preparative-scale Biotransformationsmentioning
confidence: 82%
See 2 more Smart Citations
“…8). The reaction afforded much higher substrate tolerance than previously reported bioreduction of duloxetine precursors [16,21,37,38]. For the same substrate, previous study used high concentration of whole cells of R. glutinis (42 g CDW/l), which yielded compromised stereoselectivity when substrate concentration exceeded 30 g/l [16].…”
Section: Preparative-scale Biotransformationsmentioning
confidence: 82%
“…Only the (S)-enantiomer is pharmaceutically active for the treatment of anxiety, diabetes-related pain, fibromyalgia and chronic musculoskeletal pain, including lower back pain and osteoarthritis [13][14][15]. According to the retrosynthetic strategy, several chiral alcohol precursors act as the key intermediate for (S)-duloxetine [16], which could be achieved by direct asymmetric reduction of the corresponding ketones (Fig. 1).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite the extensive development of transitional metal-catalyzed asymmetric reduction of ketones as the main approach to obtain chiral alcohols, the biocatalytic reduction has risen very rapidly, which often provides excellent activity, stereoselectivity and economic advantage under environment-friendly reaction conditions without the risk of metal contamination [1][2][3][4][5][6][7]. Both cell-free enzymes and whole microorganisms have been applied to the asymmetric reduction processes.…”
Section: Introductionmentioning
confidence: 99%
“…1) (Ren et al 2015;Tang et al 2011;Wada et al 2004;Zhang et al 2015). Immobilized cells of Saccharomyces cerevisiae have been applied to produce (S)-(−)-3-N-methylamino-1-(2-thienyl)-1-propanol with the optical purity of 99% enantiomeric excess (e.e.)…”
mentioning
confidence: 99%